0001346302-17-000002.txt : 20170522 0001346302-17-000002.hdr.sgml : 20170522 20170522120655 ACCESSION NUMBER: 0001346302-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170522 DATE AS OF CHANGE: 20170522 EFFECTIVENESS DATE: 20170522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-287198 FILM NUMBER: 17860232 BUSINESS ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: STE 1800 CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 512-498-2670 MAIL ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: STE 1800 CITY: CHICAGO STATE: IL ZIP: 60601 D 1 primary_doc.xml X0707 D LIVE 0001346302 XERIS PHARMACEUTICALS INC 180 North LaSalle Street STE 1800 Chicago IL ILLINOIS 60601 512-498-2670 DELAWARE None None Corporation true Paul Edick 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Executive Officer Director Brad Huckabee 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Executive Officer John Shannon 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Executive Officer Cary McNair 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Director Navneet Puri 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Director Robert Faulker 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Director Jonathan Rigby 180 North LaSalle Street Suite 1800 Chicago IL ILLINOIS 60601 Director Pharmaceuticals Decline to Disclose 06b false 2017-05-17 false true false 0 44999999 30050443 14949556 Series C Preferred Stock false 22 0 0 0 false XERIS PHARMACEUTICALS INC /s/ Brad Huckabee Brad Huckabee Secretary 2017-05-18